Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant AC+GM-CSF followed by Carboplatin/Nab-paclitaxel +/- Trastuzumab/Bevacizumab
NCT00254592Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Oct 2005
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, bevacizumab, sargramostim in breast cancer, sponsored by University of California, Irvine. Started Oct 2005; status: completed.
02
Drugs
paclitaxelbevacizumabsargramostim
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00254592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254592.